Home › Alpha-1 Antitrypsin Deficiency › Massachusetts
Alpha-1 Antitrypsin Deficiency clinical trials in Massachusetts
4 studies for Alpha-1 Antitrypsin Deficiency are looking for participants at sites in Massachusetts.
Cities in Massachusetts
A Study of TSRA-196 in Adults With PiZZ Alpha-1 Antitrypsin Deficiency (AATD)
- Clinical Study Center, Boston
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT07227207Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
- Brigham and Womens Hospital, Boston
- Boston Medical Center, Boston
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated May 13, 2026 · NCT05677971A Study to Evaluate the Safety and Efficacy of BEAM-302 in Adult Patients With Alpha-1 Antitrypsin Deficiency (AATD)
- Clinical Study Center, Boston
RecruitingPhase 1/2
Ages 18 to 70 · All sexes · Updated Mar 20, 2026 · NCT06389877Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)
- Boston Medical Center, Boston
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Mar 5, 2026 · NCT06165341From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.